Phase Ii Multicenter, Single Arm, Open Label Study Of Nivolumab (Nivo) In Combination With Ipilimumab (Ipi) As First Line In Adult Patients (Pts) With Metastatic Uveal Melanoma (Mum): Gem1402 Nct02626962.
JOURNAL OF CLINICAL ONCOLOGY（2017）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要